Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Natural CapsulesBOM:524654 +3.42%46 Days Payable is 142.27 as of Mar. 2026, which is 7% above its 10-year median of 132.48. GuruFocus rates BOM:524654 with a GF Score™ of 46/100 and a GF Value™ of ₹313.68 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 926 Drug Manufacturers companies, Natural Capsules ranks better than 78.51% on this metric.
The historical rank and industry rank for Natural Capsules's Days Payable or its related term are showing as below:
BOM:524654'
s Days Payable Range Over the Past 10 Years
Min: 95.13 Med: 132.48 Max: 171.16
Current: 164.98
During the past 13 years, Natural Capsules's highest Days Payable was 171.16. The lowest was 95.13. And the median was 132.48.
BOM:524654's Days Payable is ranked better than 78.51% of 926
companies
in the Drug Manufacturers industry
Industry Median: 89.975
vs BOM:524654: 164.98
Natural Capsules's Days Payable
declined
from Mar. 2025 (154.08) to Mar. 2026 (142.27).
It may suggest that Natural Capsulesaccelerated paying its suppliers.
The historical data trend for Natural Capsules's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Natural Capsules's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Capsules Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Natural Capsules's Days Payable distribution charts can be found below:
* The bar in red indicates where Natural Capsules's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Natural Capsules's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Capsules (BOM:524654) has a Days Payable of 142.27 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Natural Capsules and its competitors. This is near median its historical median of 132.48. Over the past decade, Natural Capsules' Days Payable has ranged from 95.13 to 171.16. According to the industry distribution chart, Natural Capsules ranks #199 out of 926 companies in the Drug Manufacturers industry, placing it in the top 21.5%.
Is Natural Capsules' Days Payable too high?
Natural Capsules' current Days Payable of 142.27 is near median its 10-year median of 132.48. Over the past 10 years, this metric has ranged from a low of 95.13 to a high of 171.16. The Drug Manufacturers industry median Days Payable is 89.98. Natural Capsules' value of 142.27 is 58.1% above this industry median. Based on the distribution chart, Natural Capsules ranks #199 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Natural Capsules has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Natural Capsules' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Natural Capsules ranks #199 out of 926 companies for Days Payable. This places Natural Capsules in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 89.98. Natural Capsules' value of 142.27 is 58.1% above this benchmark. Historically, Natural Capsules' own Days Payable has ranged from 95.13 to 171.16 over the past decade. While the company's 10-year median is 132.48 vs. the industry median of 89.98, Natural Capsules has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.98, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natural Capsules's current Days Payable of 142.27 is 58.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Natural Capsules and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Capsules's current Days Payable is 142.27, which is near median its own 10-year median of 132.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Capsules stock overvalued right now?
Based on GuruFocus' analysis, Natural Capsules (BOM:524654) is currently considered Possible Value Trap. The stock's GF Value™ is ₹313.68, compared to a current price of ₹155.80 — trading 50.3% below its estimated fair value. The current Days Payable is 142.27, which is near median its 10-year median of 132.48 and 58.1% above the Drug Manufacturers industry median of 89.98. Natural Capsules' overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Natural Capsules (BOM:524654), the current Days Payable is 142.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Capsules (BOM:524654) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Capsules stock appears to be undervalued.
The current stock price of ₹155.80 is trading 50.3% below its estimated GF Value™ of ₹313.68.
GuruFocus considers Natural Capsules to be Possible Value Trap.
Key valuation signals for BOM:524654:
Days Payable: 142.27 (near median its 10-year median of 132.48)
GF Value™: ₹313.68 vs. price of ₹155.80 (50.3% below fair value)
Industry Position: 58.1% above the Drug Manufacturers median (#199 of 926)
No single metric tells the full story. See the BOM:524654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Capsules Ltd is an India-based company engaged in the manufacturing and selling of empty hard gelatin capsules. The products of the company are Hard gelatin capsule shells, Hard cellulose capsule shells, Shiny gelatin capsule shells, Sweet gelatin capsule shells, Enteric capsule shells, Printed gelatin capsule shells, Vegetarian capsule shells, Fortified gelatin capsule shells, and other capsules. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products.
46GF Score
Get the complete analysis for BOM:524654
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524654 has been successfully added to your 
